CLINICAL_TRIALS
trial_result
· 2019-11-29
Clinical Trial Update: Belimumab Assessment of Safety in SLE [Phase 4]
Summary
Phase 4 trial results assessing the safety of belimumab in systemic lupus erythematosus have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED | Results posted: 2019-11-29